D'ARMINIO MONFORTE, ANTONELLA
D'ARMINIO MONFORTE, ANTONELLA
Dipartimento di Scienze della Salute
Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort
2024 A. D'ARMINIO MONFORTE, A. Tavelli, R. Salpini, L. Piermatteo, S. D'Anna, S. Carrara, V. Malagnino, V. Mazzotta, G. Brancaccio, G.C. Marchetti, D. Rosselli , E. Turco, R. Rossotti, C. Mussini, A. Antinori, Lo , C. Caputo Sergio, F. Silberstein, B. Gaeta Giovanni, V. Svicher, M. Puoti
Heavily Treatment-Experienced Persons Living with HIV Currently in Care in Italy: characteristics, Risk Factors, and Therapeutic Options - the ICONA Foundation Cohort study
2024 S.L. Caputo, M. Poliseno, A. Tavelli, R. Gagliardini, S. Rusconi, G. Lapadula, A. Antinori, D. Francisci, L. Sarmati, A. Gori, V. Spagnuolo, F. Ceccherini-Silberstein, A.D. Monforte, A. Cozzi-Lepri
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIV
2024 M. Augello, V. Bono, R. Rovito, C. Tincati, S. Bianchi, L. Taramasso, A. Di Biagio, A. Callegaro, F. Maggiolo, E. Borghi, A.D. Monforte, G. Marchetti
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis – results from the ICONA cohort in Italy, 2009-2022
2024 A. Mondi, A. Cozzi-Lepri, A. Tavelli, A. Cingolani, A. Giacomelli, G. Orofino, G. De Girolamo, C. Pinnetti, A. Gori, A. Saracino, A. Bandera, G. Marchetti, E. Girardi, C. Mussini, A. d'Arminio Monforte, A. Antinori
Pillars of long-term antiretroviral therapy success
2023 L. Taramasso, M. Andreoni, A. Antinori, A. Bandera, P. Bonfanti, S. Bonora, M. Borderi, A. Castagna, A.M. Cattelan, B.M. Celesia, S. Cicalini, A. Cingolani, A. Cossarizza, A. D'Arminio Monforte, G. D'Ettorre, A. Di Biagio, S. Di Giambenedetto, G. Di Perri, V. Esposito, E. Focà, C. Gervasoni, A. Gori, N. Gianotti, G. Guaraldi, R. Gulminetti, S. Lo Caputo, G. Madeddu, P. Maggi, G. Marandola, G.C. Marchetti, C.M. Mastroianni, C. Mussini, C.F. Perno, G. Rizzardini, S. Rusconi, M. Santoro, L. Sarmati, M. Zazzi, F. Maggiolo
Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: data from the ICONA cohort
2023 R. Gagliardini, A. Tavelli, S. Rusconi, S. Lo Caputo, V. Spagnuolo, M. Mercedes Santoro, A. Costantini, A. Vergori, F. Maggiolo, A. Giacomelli, G. Burastero, G. Madeddu, E. Quiros Roldan, A. D'ARMINIO MONFORTE, A. Antinori, A. Cozzi-Lepri
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
2023 L. Piemonti, G. Landoni, A. Voza, M. Puoti, I. Gentile, N. Coppola, S. Nava, A. Mattei, F. Marinangeli, G. Marchetti, P. Bonfanti, C.M. Mastroianni, M. Bassetti, E. Crisafulli, P.A. Grossi, A. Zangrillo, A. Desai, M. Merli, M. Foggia, M. Carpano, L. Schiavoni, A. D’Arminio Monforte, L. Bisi, G. Russo, F. Busti, C. Rovelli, E. Perrotta, G. Goisis, E.M. Gavioli, S. Toya, M. De Pizzol, F. Mantelli, M. Allegretti, E.M. Minnella
Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19
2023 G. Marchetti, R. Rovito, V. Bono, P. Bonara, F. Bai, A.D. Monforte
HIV-Indicator condition guided testing in a hospital setting
2023 D. Barbanotti, C. Tincati, A. Tavelli, A. Santoro, M. Sala, T. Bini, A. De Bona, A. D'ARMINIO MONFORTE, G.C. Marchetti
Differences in clinical characteristics and quantitative lung CT features between vaccinated and not vaccinated hospitalized COVID-19 patients in Italy
2023 D. Chiumello, A. Tavelli, L. Serio, S. De Benedittis, T. Pozzi, R. Maj, M. Velati, S. Brusatori, R. D’Albo, C. Zinnato, G. Marchetti, L. Camporota, S. Coppola, A. D’Arminio Monforte
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA Study
2023 A. D'ARMINIO MONFORTE, M. Puoti, A. Tavelli, A. Saracino, S. Rusconi, S. Antinori, M. Sala, A. Mondi, B. MAURIZIO CELESIA, A. Cozzi-Lepri, L. Taramasso, A. Antinori
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort
2023 A. d'Arminio Monforte, A. Tavelli, R. Rossotti, R. Gagliardini, A. Saracino, S. Lo Caputo, M. Sala, E. Quiros-Roldan, C. Mussini, E. Girardi, A. Cozzi-Lepri, A. Antinori, M. Puoti
Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection
2023 M. Augello, V. Bono, R. Rovito, C. Tincati, A. D'ARMINIO MONFORTE, G.C. Marchetti
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio
2023 A. Vergori, A. Tavelli, G. Matusali, A.M. Azzini, M. Augello, V. Mazzotta, G.F. Pellicanò, A. Costantini, A. Cascio, A. De Vito, L. Marconi, E. Righi, A. Sartor, C. Pinnetti, F. Maggi, F. Bai, S. Lanini, S. Piconi, G. Levy Hara, G. Marchetti, M. Giannella, E. Tacconelli, A. d’Arminio Monforte, A. Antinori, A. Cozzi-Lepri
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres
2022 A. Comelli, C. Genovese, A. Lombardi, C. Bobbio, L. Scudeller, U. Restelli, A. Muscatello, S. Antinori, P. Bonfanti, S. Casari, A. Castagna, F. Castelli, A.D. Monforte, F. Franzetti, P. Grossi, M. Lupi, P. Morelli, S. Piconi, M. Puoti, L. Pusterla, A. Regazzetti, M. Rizzi, S. Rusconi, V. Zuccaro, A. Gori, A. Bandera
Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney Disease
2022 P. Ciceri, V. Bono, L. Magagnoli, M. Sala, A. D'ARMINIO MONFORTE, A. Galassi, A. Barassi, G.C. Marchetti, M.G. Cozzolino
Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects
2022 V. Bono, C. Tincati, L. Van Den Bogaart, E.S. Cannizzo, R. Rovito, M. Augello, A. De Bona, A. D'Arminio Monforte, L. Milazzo, G. Marchetti
Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects
2022 D. Mondatore, F. Bai, M. Augello, M. Giovenzana, A. Pisani Ceretti, V. Bono, E. Opocher, A. d’Arminio Monforte, G.C. Marchetti, C. Tincati
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study
2022 L. Valenti, S. Pelusi, A. Aghemo, S. Gritti, L. Pasulo, C. Bianco, C. Iegri, G. Cologni, E. Degasperi, R. D'Ambrosio, P. del Poggio, A. Soria, M. Puoti, I. Carderi, M.G. Pigozzi, C. Carriero, A. Spinetti, V. Zuccaro, M. Memoli, A. Giorgini, M. Vigano, M.G. Rumi, T. Re, O. Spinelli, M.C. Colombo, T. Quirino, B. Menzaghi, G. Lorini, A. Pan, A. D'Arminio Monforte, E. Buscarini, A. Autolitano, P. Bonfanti, N. Terreni, G. Aimo, M. Mendeni, D. Prati, P. Lampertico, M. Colombo, S. Fagiuoli
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting
2022 L. Greenberg, L. Ryom, B. Neesgaard, J.M. Miró, L. Dahlerup Rasmussen, R. Zangerle, K. Grabmeier-Pfistershammer, H.F. Günthard, K. Kusejko, C. Smith, C. Mussini, M. Menozzi, F. Wit, M. Van Der Valk, A. d'Arminio Monforte, S. De Wit, C. Necsoi, A. Pelchen-Matthews, J. Lundgren, L. Peters, A. Castagna, C. Muccini, J.J. Vehreschild, C. Pradier, A. Bruguera Riera, A. Sönnerborg, K. Petoumenos, H. Garges, F. Rogatto, N. Dedes, L. Bansi-Matharu, A. Mocroft